Aspira Women's Health Secures $1.05 Million Subordinated Loan from Agile Lending

Aspira Women’s Health Inc. has entered into a new Subordinated Business Loan and Security Agreement with Agile Lending, LLC as lead lender and Agile Capital Funding, LLC as collateral agent. Under the terms of the agreement, dated January 30, 2026, the lenders have agreed to provide Aspira and certain subsidiary co-borrowers with a secured term loan evidenced by a Subordinated Secured Promissory Note in the principal amount of $1,050,000. The note, which carries interest charges of $441,000 if paid on time, is scheduled to mature on August 26, 2026. The loan is subordinated to all senior indebtedness and is secured by substantially all of the company’s and co-borrowers’ personal property, subject to customary exclusions. Proceeds from the loan will be used for general corporate purposes. The agreement includes customary covenants and events of default, and is governed by the laws of the Commonwealth of Virginia. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aspira Women’s Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000926617-26-000007), on January 30, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here